ArticleBiological trace element research2026
Boric Acid Stimulates Wound Closure and Modulates EMT-Related Gene Expression in HaCaT Cells.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Boric acid (BA), a boron-based compound with known antimicrobial and anti-inflammatory properties, has recently attracted attention for its potential role in enhancing wound healing. However, its effects on keratinocyte-mediated skin repair at the molecular level remain underexplored. This study aimed to evaluate the impact of BA on wound healing using HaCaT keratinocytes. Cell viability was assessed following 24 and 48 h exposure to increasing concentrations of BA (0-2500 µM). Non-cytotoxic concentrations (10, 100 and 250 µM) were selected for subsequent analyses. Scratch assays were performed to evaluate cell migration. qRT-PCR was used to evaluate the expression levels of key genes associated with cell adhesion, proliferation, and epithelial-mesenchymal transition (CTNNA1, CTNNB1, ILK, OCLN, VIM, MMP7, MMP9, ZEB1 and ZEB2). BA treatment significantly enhanced wound closure in a dose-dependent manner, with the 250 µM group showing the highest closure rate (~ 50%) at 48 h. BA upregulated CTNNA1, CTNNB1, ILK, VIM, OCLN, MMP7 and ZEB2 expression levels. In contrast, ZEB1 expression was slightly decreased, while MMP9 level remained unchanged. At the protein level, VIM and ZEB2 were both upregulated. These findings suggest that BA promotes wound healing in keratinocytes by enhancing cell migration and modulating the expression of key genes involved in tissue regeneration. BA may represent a promising candidate for topical wound healing therapies.
Indexed as
Identifiers
41428324What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.